This guest blog is one in a series by sponsors of the 2024 PQA Leadership Summit on how MedWatchers is using AI to empower better patient care. PQA does not endorse, recommend or favor any product, service or organization that is a sponsor.
This guest blog is one in a series by sponsors of the 2024 PQA Leadership Summit on why a large diverse clinical pharmacy network is so important to payer performance. PQA does not endorse, recommend or favor any product, service or organization that is a sponsor.
This guest blog is one in a series by sponsors of the 2024 PQA Annual Meeting on a survey which highlights opportunities for pharmacies and payers to boost medication compliance. PQA does not endorse, recommend or favor any product, service or organization that is a sponsor.
This guest blog is one in a series by sponsors of the 2023 PQA Leadership Summit on elevating clinical quality assurance. The views shared in this series are those of the author and do not reflect any PQA positions.
This guest blog is one in a series by sponsors of the 2023 PQA Leadership Summit on EQUIPP enhanced services. The views shared in this series are those of the author and do not reflect any PQA positions.
This guest blog is one in a series by sponsors of the 2022 PQA Annual Meeting on the utilization of the EQUIPP platform to promote performance improvement on medication-related quality measures while engaging transparency between health plans and pharmacies. The views shared in this series are those of the author and do not reflect any PQA positions.
This guest blog is one in a series by sponsors of the 2022 PQA Annual Meeting on the application of measures into daily practice. The views shared in this series are those of the author and do not reflect any PQA positions
Dave Hachey, PharmD, is one of PQA’s expert faculty for the new 3-hour continuing education course, Measuring Quality to Improve HIV Medication Use. Hachey is a Professor of Family Medicine at Idaho State University. He has more than 20 years of experience in the fields of HIV and family medicine, as well as more than 10 years of experience in hepatitis C management. In addition to discussing treatment and prevention modalities, Hachey outlines key indicators for the successful treatment of HIV
This guest blog is one in a series by sponsors of the 2021 PQA Annual Meeting on emerging trends in medication use quality. The views shared in this series are those of the author and do not reflect any PQA positions.
This guest blog is one in a series by sponsors of the 2021 PQA Annual Meeting on emerging trends in medication use quality. The views shared in this series are those of the author and do not reflect any PQA positions.
This guest blog is one in a series by sponsors of the 2021 PQA Annual Meeting on emerging trends in medication use quality. The views shared in this series are those of the author and do not reflect any PQA positions.
